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Background.Increasinglevelsofobesityoverrecentdecadeshavebeenexpectedtoleadtoanepidemicofdiabetesandasubsequent
reduction in life expectancy, but instead all-cause and cardiovascular-speciﬁc mortality rates have decreased steadily in most
developed countries and life expectancy has increased. Methods. This paper suggests several factors that may be masking the eﬀects
of obesity on life expectancy. Results. It is possible that health and life expectancy gains could be even greater if it was not for the
increasing prevalence of extreme obesity. It is also possible that the principal impact of obesity is on disability-free life expectancy
rather than on life expectancy itself. Conclusion. If the principal impact of obesity were through disability-free life expectancy
rather than on life expectancy itself, this would have substantial implications for the health of individuals and the future burden
on the health care system.
1.Introduction
Obesity has reached unprecedented levels globally and its
rise is projected to continue. This has caused widespread
concern, considering the associations between obesity and
a range of adverse health conditions. There is a widely
held view that the increasing rates of obesity will lead to
an epidemic of diabetes, other chronic conditions, and a
subsequentreduction inlife expectancy.Howeverthe picture
is complicated. Since the 1960s all-cause and cardiovascular-
speciﬁc mortality rates have decreased steadily in most
developed countries, and life expectancy has consistently
increased [1]. The aim of this paper is to suggest several
reasons for the discrepancy between increasing levels of
obesity and gains in life expectancy, and those factors may
be masking the eﬀects of obesity on life expectancy.
A better understanding of the way in which obesity
aﬀects health and longevity will help determine the most
appropriate response to increasing levels of excess body
weight and assist our understanding of the likely impact of
obesity on the health of individuals and the future burden on
the health care system.
2. Population Trends
An increasing prevalence of obesity has been observed in
most countries worldwide. This is considered to have led to
an “epidemic” of type II diabetes. The progression of this
epidemic, in tandem with cardiovascular disease and several
othermorbiditiesassociatedwithobesity,ispredictedtoslow
or reverse the decline in mortality that has been noted in
most Western countries over the past 30–40 years [1].
The data accumulated to date have provided relatively
little evidence in support of this view. Levels of obesity
have been increasing since the 1950s (albeit slowly, initially)
in the USA and other developed countries [2]. Over the
same period, life expectancy has continued to increase at an
undiminished rate [3], and cardiovascular-speciﬁc mortality
rates have also decreased continually [4].
Why the Contradiction? A number of factors may explain
the apparent discrepancy.
(1) Improvement in Other Risk Factors. It is possible that
the deleterious impact of obesity is outweighed by other2 Journal of Obesity
factors favourably inﬂuencing life expectancy. Capewell et al.
(2010) have reported that in the United States three of the
six major risk factors for CHD—total cholesterol, prevalence
of smoking, and physical activity levels—improved between
1988 and 2003 [5]. There was also a lowering of blood
pressure in men [5]. Under this scenario, the rate of decline
of all-cause and CVD mortality might be faster still if it was
not for the increasing prevalence of diabetes [5, 6], for which
there is a clear association with heart disease [7]. Examples
of factors driving mortality down include population-wide
c h a n g e ss u c ha sr e d u c t i o n si nt h ep r e v a l e n c ea n di n t e n s i t yo f
smoking [7]. However, Stewart et al. (2009) have predicted
that over the next decade the negative eﬀects of increasing
levels of obesity will outweigh the beneﬁts from reductions
in the prevalence of smoking [7]. However, Peto et al.
(2010) critiqued this ﬁnding, suggesting that Stewart et
al. (2009) have overestimated the hazards of obesity and
underestimated the hazards of smoking [8].
(2) Pharmacological Treatment. There is the possibility of
improved medical interventions in some of the pathways
linking obesity to CVD and all-cause mortality. For example,
improved control of hypertension and better management of
dyslipidaemia may blunt the impact of obesity on adverse
health outcomes [3, 9]. Hypertension has been fairly well
controlled in recent years, and there has been increased use
of statins, angiotensin pathway inhibitors, and aspirin, all
of which may be contributing to the limited eﬀect of rising
obesity levels.
(3) Prevalence of More Extreme Obesity. The impact of
obesity may have been overestimated because its principal
adverse eﬀects are experienced by a minority of the popu-
lation. The most robust estimates of the association between
BMI and mortality, from the Prospective Studies Collabora-
tion of 900,000 adults in 57 prospective studies, suggests that
the mortality risk from excess body weight increases from
a BMI of 25 but is not substantial until BMI exceeds 32–
35 [10]. Between 15 and 25 percent of the US population
have BMIs in this range. It is a signiﬁcant proportion but
nevertheless a clear minority of the population, at least
currently. Although signiﬁcant increases in the prevalence of
severe obesity (BMI > 40) have been reported in a number
of countries [11, 12], the risk for this group is outweighed
by the considerably less signiﬁcant risks associated with body
weight in the majority of the population (Figure 1).
( 4 )R e v e r s a lo fR e l a t i o n s h i pi nO l dA g e .In old age those of
lowbody weightareathigherriskofdisability (limitations to
activities of daily living) and mortality [13]. The relationship
between obesity and health appears to reverse in old age.
For example, Diehr et al. (1988) found little relationship
between BMI and mortality in older adults, except for
those of very low body weight, who had a higher mortality
than others [13]. It is likely, however, that this reversal
of the obesity and health relationship in older people is
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Figure 1: Risk relationships between body weight and mortality.
(5) Body Weight Per Se Not Associated with Mortality. It is
possible that body weight is not a signiﬁcant risk factor for
mortality. Body weight may act simply as a surrogate for
a constellation of attributes of lifestyle, in particular diet,
physical activity level, and genetic factors [14]. If this were
the case, obese individuals would represent a heterogeneous
g r o u po fh i g hb o d yw e i g h td u et oav a r i e t yo fr e a s o n s ,
some of which may not be so strongly related as others to
morbidity or mortality.
(6) Latency Period and Cohort Eﬀect. It is possible that
the deleterious impact of recent obesity trends has not yet
aﬀected life expectancy due to a considerable latency period
between onset of obesity and disease. Recent cohorts of the
US population are experiencing a greater magnitude and
duration of obesity over their lifetime [15]. The duration of
exposure to obesity has been reported to have an important
impact on disease and mortality [16]. Thus, it is possible
that the adverse impact of obesity is a function of both
severity and duration, and that with more recent cohorts
the deleterious impact of obesity on life expectancy will be
observed [15]. Indeed, recent mortality statistics (2008) in
theUSdemonstrate,fortheﬁrsttimeinover25years,aslight
decline in US life expectancy [17]. Nevertheless, in this same
report diabetes and cardiovascular mortality rates maintain
a continual decline. Furthermore, in an assessment of
overweight and obesity on the risk of cardiovascular disease
and mortality in middle-aged men, Arnlov et al. (2010)
[18] observed a lag time of only 10 years. Additionally, the
positive eﬀects of weight loss after bariatric surgery on con-
ditionssuchasdiabetes,hypertension,anddyslipidemiahave
occurredinamuchshorterperiod(lessthantwoyears)[19].
(7) The Obesity Paradox. There is the “obesity paradox”
in which survival from acute events such as myocardialJournal of Obesity 3
infarction, heart failure, and dialysis for renal failure is
improved in patients with overweight and obesity [20–22].
The mechanism for this observation is not known but is
unlikely to be simply that more severely ill patients have lost
weight on account of the severity of their illness. It is also
possible that diseases such as hypertension and diabetes may
be more aggressive and of a diﬀerent origin in lean individu-
als than when they are associated with obesity. For example,
among patients with a history of hypertension and coronary
artery disease, Uretsky et al. (2007) found that overweight
and obesity (classes I to III) were associated with a lower
risk of morbidity and mortality compared with normal-
weight patients, despite poorer blood pressure control
[20].
Thus, considerations such as lag time, duration of exposure
toobesity,andincreasingproportions ofthepopulationwith
severe obesity suggest that obesity may in the future have a
considerable impact on life expectancy. However there are
also important reasons—improved control of hypertension,
shape of BMI-mortality relationship, and body weight as
a surrogate marker of lifestyle—why obesity may not be
strongly linked to life expectancy, except at the extremes
of the weight distribution. Rather, the principle impact of
obesity may be on disability-free life expectancy. Several
studies suggest an association between body weight and a
higher risk of becoming disabled [23–25], although others
dispute this [3, 26].
3. Conclusion
Several reasons explain why the impact of obesity on
l i f ee x p e c t a n c ym a yb em o r ec o m p l e xt h a ni sc o m m o n l y
recognised. It is possible that the principal impact of obesity
is on disability-free life expectancy rather than on life
expectancy itself. It is also possible that health and life
expectancy gains could be even greater if it was not for the
increasing prevalence of extreme obesity.
It is important to understand why life expectancy is
generally continuing to improve despite a high and increas-
ing prevalence of obesity. Further research in this area and
careful monitoring of recent cohorts and future trends will
assist policy makers with determining the most appropriate
response to increasing levels of obesity. If only those with
more extreme obesity are facing substantial health and
mortality risks, this will help inform as to the appropriate
mix of population and high-risk (targeting people already
obese, or at risk of signiﬁcant weight gain, e.g.) approaches
to obesity reduction. If the principle impact of obesity
is on disability-free life expectancy rather than on life
expectancy itself, this has substantial implications for the
heath of individuals and the future burden on the health care
system.
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